Developing a new optical method to measure activity in the retina
Optoretinography: All-optical measures of functional activity in the human retina
['FUNDING_U01'] · UNIVERSITY OF WASHINGTON · NIH-10917168
This study is testing a new, gentle way to look at how well your retina is working by using light, which could help doctors see how effective treatments are for retinal diseases.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10917168 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a non-invasive optical technique called optoretinography (ORG) to monitor retinal function and assess the effectiveness of treatments for retinal diseases. By using advanced imaging methods, the researchers aim to visualize how retinal neurons respond to light, providing insights into their health and functionality. The ORG technique is designed to offer high sensitivity and resolution, allowing for detailed observation of neural activity at various scales and timeframes. This innovative approach could significantly enhance our understanding of retinal diseases and improve clinical assessments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with retinal diseases who require monitoring of their retinal function.
Not a fit: Patients with healthy retinas or those without retinal diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better monitoring and treatment options for patients with retinal diseases.
How similar studies have performed: Other research has shown promise in using optical techniques for assessing retinal function, making this approach both innovative and grounded in prior successes.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SABESAN, RAMKUMAR — UNIVERSITY OF WASHINGTON
- Study coordinator: SABESAN, RAMKUMAR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.